| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4217380 | Thoracic Surgery Clinics | 2008 | 5 Pages |
Abstract
Simply defined, N2 disease in non-small cell lung cancer (NSCLC) is the presence of ipsilateral mediastinal nodal metastases. This definition does little justice to what is in actuality a heterogeneous and challenging patient population. The presence of ipsilateral mediastinal nodal metastases (N2 disease) in NSCLC is a poor prognostic sign. This article demonstrates that the definition of N2 disease includes many subgroupings with widely disparate effects on prognosis.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Edmund S. MD, Ara A. MD,